Catherine Racowsky

Brigham and Women's Hospital, Harvard University

Papers

3

Total Citations

108

H-Index

3

About

Catherine Racowsky is a pioneering reproductive biologist whose work has fundamentally reshaped fertility medicine, most notably through her leadership in uterus transplantation (UTx). Her research centers on absolute uterine factor infertility (AUFI), a condition once considered an irreversible barrier to childbearing. Racowsky’s major contributions include advancing UTx from experimental animal models to a clinically viable human therapy, culminating in the landmark 2014 birth of a healthy baby after transplantation. Her 2023 paper, “Uterus transplantation: from research, through human trials and into the future,” with 89 citations, documents this transformative journey and serves as a cornerstone reference in the field. She has also authored influential analyses comparing UTx to surrogacy, addressing the ethical and medical dilemmas of AUFI, and co-authored the second report of the International Society of Uterus Transplantation (ISUTx) registry, which tracks global UTx activities from 2000 to 2024. With over 91 documented UTx cases worldwide, Racowsky’s work has directly enabled women with Mayer-Rokitansky-Küster-Hauser syndrome and other causes of AUFI to achieve biological motherhood. Her research continues to shape clinical protocols, ethical guidelines, and international collaboration in reproductive transplantation, cementing her legacy as a transformative figure in fertility science.

Research Focus

Key Achievements

3
H-Index
3
Papers
108
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Uterus transplantation: from research, through human trials and into the future
89 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Brigham and Women's Hospital, Harvard University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago